Skip to main content
. 2016 Feb 19;7(12):14940–14950. doi: 10.18632/oncotarget.7496

Figure 1. Identification of potential CSC marker of murine melanoma cells.

Figure 1

A. The expression of CD133, ABCB5 and CD144 on the cells obtained by three rounds of selection. B. mRNA levels of subpopulation stained with CD133 and ABCB5. Data are presented as mean ± SD. *P < 0.05 for CD133+ versus CD133− or ABCB5+ versus ABCB5−. C. Limiting dilution assay showing tumor initiating ability of CD133+, CD133−, ABCB5+, ABCB5− in vivo. A series number of cells were inoculated into six mice per group. Tumor development was recorded daily. TIF was calculated using the ELDA software. D. Western blots for ABCB5 expression by CD44+CD133+CD24+ versus CD44−CD133−CD24− melanoma cell (gapdh-loading control).